Procedures
migraine, headache, pain
MIGRAINE, COMPLICATIONS
In the present non‐inferiority randomized comparison trial, the possible concealment (i.e., keeping an optimum strategy (Karanicolas et al., We used a baseline headache diary over 3 months to measure pain duration, frequency, and intensity. The trial measures were administered at the baseline, post‐test, and 12‐month follow‐up. Moreover, weekly telephone follow‐ups were made to enquire about the participants’ experiences of pain, use of prescribed or non‐prescribed medication, menstrual cycle, sleeping pattern, drinking water, or other related behaviors for both interventional and control groups. The telephone calls also helped minimize the participants’ dropouts.In case of experiencing the symptoms of migraine attacks or complications that could affect their regular daily lives, the related research assistant reassured the participants that they could have control visits with their physician during the trial. However, none of the participants in the interventional groups reported referring to their physician or resuming the use of migraine prescribed or non‐prescribed medication at any of the interventional groups' phone calls or follow‐up assessments. Therefore, the interventional groups had no data on prescribed or non‐prescribed medication relapse. The same experimenters administered all trial measures at the baseline, post‐test, and follow‐up assessments.